close
Share with your friends

Site Selection for Life Sciences Companies in Europe

Choosing the right location when setting up or expanding operations is no easy task. Read our insights into the most important things to consider.

Read our insights into the key factors when choosing the right site for your operations.

Site Selection Europe

Whether for your regional headquarters, shared service center, or your manufacturing, warehousing or R&D facility, there are many potentially attractive locations to consider.

In this fifth edition of Site Selection for Life Sciences Companies in Europe, we compare and contrast the European countries in terms of general business environment, infrastructure, innovation and R&D, availability of talent, and much more.

We also share our insights into latest developments. From the potential for Life Sciences businesses to benefit from EU funding and industrial strategies, to opportunities for contract manufacturers, to first-time product launches, our perspective can help you determine the optimal site for your operations.

kpmg.formbuilder.subscribedescription1

kpmg.formbuilder.subscribedescription2

You’ve successfully logged in.

Please close this pop-up to return to the page.

Please provide the following information to register.

The email format is incorrect. This field is required Incorrect email format. Please enter corporate email address.
hans@muster.com
This field is required
Hans
This field is required
Muster
This field is required
This field is required
Company
This field is required
Function (optional)

Yes, I would like to receive newsletters, insights and event invitations from KPMG Switzerland by email.

Note: You will only receive email communications based on the selection you have made in your profile. You can unsubscribe from our communication channels and delete your account at any time.

I confirm that I have read and understood the KPMG Online Privacy Policy.

Featured insights

Find out more about our key study findings.

placeholder

A growth in industrial strategies

Discover the opportunities presented by a resurgence of state-led programs to stimulate economic growth and improve the resilience of critical industries such as Life Sciences.

placeholder

A decline in tax relevance

Read how tax rates and incentives remain important, but BEPS 2.0’s planned minimum rates has demoted tax from its previous role as a primary driver of site selection.

placeholder

A boost in industry capabilities

Find out why companies launching their first products are doing so without big pharma, as financing becomes easier to secure and the number of experienced advisors grows.

Your key contact

KPMG’s dedicated Life Sciences practice helps companies choose the right site for their unique needs. Talk to us if you are considering where to expand or set up your operations in Europe.

André Guedel

André Guedel

Director, Head of International Headquarters


> Contact me

Discover more

Interesting topics for you:

Site Selection for Life Sciences Companies in Asia

Navigate the landscape of Asia’s most dynamic and diverse Life Sciences markets.

> Further information

Life Sciences

We help pharmaceutical and biotech companies make better business decisions.

> Read more

KPMG Voice

Our blog offers a clear picture of current trends and challenges facing the Swiss economy.

> More insights

informative image